# OnCo record javelin-bladder-100 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/javelin-bladder-100/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "javelin-bladder-100", "NCT02603432" ;
  schema:name "JAVELIN Bladder 100"@en ;
  schema:description "Starting immunotherapy right after chemotherapy, rather than waiting for relapse, lengthened survival by about seven months."@en ;
  schema:url <https://onco.cc/trials/javelin-bladder-100/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02603432> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2016-04-25" ;
  onco:cancers <https://onco.cc/cancers/urothelial/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:drugs <https://onco.cc/drugs/avelumab/> ;
  onco:companies <https://onco.cc/companies/merck-kgaa/>, <https://onco.cc/companies/pfizer/> ;
  onco:people <https://onco.cc/people/thomas-powles/> .
